Skip to main content
SpringerLink
Log in

Cord Blood Transplants for Myeloid Malignancies in Adults

  • Chapter
  • First Online:
Cord Blood Transplantations

  • 377 Accesses

Abstract

Allogeneic hematopoietic stem cell transplantation (HSCT) remains the only potentially curative therapy for the majority of myeloid malignancies. Donor options beyond siblings are expanding and outcomes with these donor sources are improving. The current book chapter investigates the cord blood transplant outcomes for acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and myelofibrosis. Topics of cord blood transplant in elderly patients and a comparison of cord blood and haploidentical donors are also discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Gluckman E, Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW, Devergie A et al (1989) Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 321(17):1174–1178

    Article  CAS  PubMed  Google Scholar 

  • Kurtzberg J, Laughlin M, Graham ML, Smith C, Olson JF, Halperin EC et al (1996) Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 335(3):157–166

    Article  CAS  PubMed  Google Scholar 

  • Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, McGlave PB, Miller JS et al (2005) Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 105(3):1343–1347

    Article  CAS  PubMed  Google Scholar 

  • Brunstein CG, Gutman JA, Weisdorf DJ, Woolfrey AE, Defor TE, Gooley TA et al (2010) Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood. Blood 116(22):4693–4699

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Weisdorf D, Eapen M, Ruggeri A, Zhang MJ, Zhong X, Brunstein C et al (2014) Alternative donor transplantation for older patients with acute myeloid leukemia in first complete remission: a center for international blood and marrow transplant research-eurocord analysis. Biol Blood Marrow Transplant 20(6):816–822

    Article  PubMed  PubMed Central  Google Scholar 

  • Peffault de Latour R, Brunstein CG, Porcher R, Chevallier P, Robin M, Warlick E et al (2013a) Similar overall survival using sibling, unrelated donor, and cord blood grafts after reduced-intensity conditioning for older patients with acute myelogenous leukemia. Biol Blood Marrow Transplant 19(9):1355–1360

    Article  PubMed  Google Scholar 

  • Warlick ED, Peffault de Latour R, Shanley R, Robin M, Bejanyan N, Xhaard A et al (2015) Allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia: similar outcomes regardless of donor type. Biol Blood Marrow Transplant 21(2):357–363

    Article  PubMed  Google Scholar 

  • Sierra J, Perez WS, Rozman C, Carreras E, Klein JP, Rizzo JD et al (2002) Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia. Blood 100(6):1997–2004

    CAS  PubMed  Google Scholar 

  • Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D (2009) Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden. Biol Blood Marrow Transplant 15(1):30–38

    Article  PubMed  Google Scholar 

  • Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G et al (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89(6):2079–2088

    CAS  PubMed  Google Scholar 

  • Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Sole F et al (2012) Revised international prognostic scoring system for myelodysplastic syndromes. Blood 120(12):2454–2465

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cutler CS, Lee SJ, Greenberg P, Deeg HJ, Perez WS, Anasetti C et al (2004) A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome. Blood 104(2):579–585

    Article  CAS  PubMed  Google Scholar 

  • Koreth J, Pidala J, Perez WS, Deeg HJ, Garcia-Manero G, Malcovati L et al (2013) Role of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an international collaborative decision analysis. J Clin Oncol 31(21):2662–2670

    Article  PubMed  PubMed Central  Google Scholar 

  • Ustun C, Trottier BJ, Sachs Z, DeFor TE, Shune L, Courville EL et al (2015) Monosomal karyotype at the time of diagnosis or transplantation predicts outcomes of allogeneic hematopoietic cell transplantation in myelodysplastic syndrome. Biol Blood Marrow Transplant 21(5):866–872

    Article  PubMed  PubMed Central  Google Scholar 

  • Della Porta MG, Alessandrino EP, Bacigalupo A, van Lint MT, Malcovati L, Pascutto C et al (2014) Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R. Blood 123(15):2333–2342

    Article  CAS  PubMed  Google Scholar 

  • Trottier BJ, Sachs Z, TE DF, Shune L, Dolan M, Weisdorf DJ et al (2015) Novel disease burden assessment predicts allogeneic transplantation outcomes in myelodysplastic syndrome. Bone Marrow Transplant 51:199

    Article  PubMed  PubMed Central  Google Scholar 

  • Saber W, Cutler CS, Nakamura R, Zhang MJ, Atallah E, Rizzo JD et al (2013) Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS). Blood 122(11):1974–1982

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lim Z, Brand R, Martino R, van Biezen A, Finke J, Bacigalupo A et al (2010) Allogeneic hematopoietic stem-cell transplantation for patients 50 years or older with myelodysplastic syndromes or secondary acute myeloid leukemia. J Clin Oncol 28(3):405–411

    Article  PubMed  Google Scholar 

  • Robin M, Sanz GF, Ionescu I, Rio B, Sirvent A, Renaud M et al (2011) Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of eurocord and CLWP of EBMT. Leukemia 25(1):75–81

    Article  CAS  PubMed  Google Scholar 

  • Robin M, Ruggeri A, Labopin M, Niederwieser D, Tabrizi R, Sanz G et al (2015) Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen: a collaborative study from Eurocord (cord blood Committee of Cellular Therapy & Immunobiology working party of EBMT) and chronic malignancies working party. Biol Blood Marrow Transplant 21(3):489–495

    Article  PubMed  Google Scholar 

  • Pourhassan H, DeFor T, Trottier B, Dolan M, Brunstein C, Bejanyan N, Ustun C, Warlick ED (2016) MDS disease characteristics, not donor source, predict hematopoietic stem cell transplant outcomes. Bone Marrow Transplant 52:532–538

    Google Scholar 

  • Majhail NS, Brunstein CG, Shanley R, Sandhu K, McClune B, Oran B et al (2012) Reduced-intensity hematopoietic cell transplantation in older patients with AML/MDS: umbilical cord blood is a feasible option for patients without HLA-matched sibling donors. Bone Marrow Transplant 47(4):494–498

    Article  CAS  PubMed  Google Scholar 

  • Takagi S, Ota Y, Uchida N, Takahashi K, Ishiwata K, Tsuji M et al (2010) Successful engraftment after reduced-intensity umbilical cord blood transplantation for myelofibrosis. Blood 116(4):649–652

    Article  CAS  PubMed  Google Scholar 

  • Robin M, Giannotti F, Deconinck E, Mohty M, Michallet M, Sanz G et al (2014) Unrelated cord blood transplantation for patients with primary or secondary myelofibrosis. Biol Blood Marrow Transplant 20(11):1841–1846

    Article  PubMed  Google Scholar 

  • Murata M, Nishida T, Taniguchi S, Ohashi K, Ogawa H, Fukuda T et al (2014) Allogeneic transplantation for primary myelofibrosis with BM, peripheral blood or umbilical cord blood: an analysis of the JSHCT. Bone Marrow Transplant 49(3):355–360

    Article  CAS  PubMed  Google Scholar 

  • Tanaka M, Miyamura K, Terakura S, Imai K, Uchida N, Ago H et al (2015) Comparison of cord blood transplantation with unrelated bone marrow transplantation in patients older than fifty years. Biol Blood Marrow Transplant 21(3):517–525

    Article  PubMed  Google Scholar 

  • Konuma T, Tsukada N, Kanda J, Uchida N, Ohno Y, Miyakoshi S et al (2016) Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older. Am J Hematol 91(5):E284–E292

    Article  PubMed  Google Scholar 

  • Majhail NS, Brunstein CG, Tomblyn M, Thomas AJ, Miller JS, Arora M et al (2008) Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor. Biol Blood Marrow Transplant 14(3):282–289

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sandhu KS, Brunstein C, DeFor T, Bejanyan N, Arora M, Warlick E et al (2016) Umbilical cord blood transplantation outcomes in acute myelogenous leukemia/myelodysplastic syndrome patients aged >/=70 years. Biol Blood Marrow Transplant 22(2):390–393

    Article  PubMed  Google Scholar 

  • Peffault de Latour R, Brunstein CG, Porcher R, Chevallier P, Robin M, Warlick E et al (2013b) Similar overall survival using sibling, unrelated donor, and cord blood grafts after reduced-intensity conditioning for older patients with acute myelogenous leukemia. Biol Blood Marrow Transplant 19(9):1355–1360

    Article  PubMed  Google Scholar 

  • Warlick ED, DeFor T, Blazar BR, Burns L, Verneris MR, Ustun C et al (2012) Successful remission rates and survival after lymphodepleting chemotherapy and donor lymphocyte infusion for relapsed hematologic malignancies postallogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 18(3):480–486

    Article  PubMed  Google Scholar 

  • Deol A, Lum LG (2010) Role of donor lymphocyte infusions in relapsed hematological malignancies after stem cell transplantation revisited. Cancer Treat Rev 36(7):528–538

    Article  PubMed  PubMed Central  Google Scholar 

  • Bejanyan N, Oran B, Shanley R, Warlick E, Ustun C, Vercellotti G et al (2014) Clinical outcomes of AML patients relapsing after matched-related donor and umbilical cord blood transplantation. Bone Marrow Transplant 49(8):1029–1035

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kasamon YL, Bolanos-Meade J, Prince GT, Tsai HL, McCurdy SR, Kanakry JA et al (2015) Outcomes of nonmyeloablative HLA-haploidentical blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in older adults. J Clin Oncol 33(28):3152–3161

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Armand P, Kim HT, Cutler CS, Ho VT, Koreth J, Ritz J et al (2008) A prognostic score for patients with acute leukemia or myelodysplastic syndromes undergoing allogeneic stem cell transplantation. Biol Blood Marrow Transplant 14(1):28–35

    Article  CAS  PubMed  Google Scholar 

  • Ruggeri A, Labopin M, Sanz G, Piemontese S, Arcese W, Bacigalupo A et al (2015) Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia. Leukemia 29(9):1891–1900

    Article  CAS  PubMed  Google Scholar 

  • Ruggeri A, Paviglianiti A, Gluckman E, Rocha V (2016) Impact of HLA in cord blood transplantation outcomes. HLA 87:413–421

    Article  CAS  PubMed  Google Scholar 

  • Gluckman E, Rocha V, Arcese W, Michel G, Sanz G, Chan KW et al (2004) Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 32(4):397–407

    Article  CAS  PubMed  Google Scholar 

  • Sanz J, Jaramillo FJ, Planelles D, Montesinos P, Lorenzo I, Moscardo F et al (2014) Impact on outcomes of human leukocyte antigen matching by allele-level typing in adults with acute myeloid leukemia undergoing umbilical cord blood transplantation. Biol Blood Marrow Transplant 20(1):106–110

    Article  CAS  PubMed  Google Scholar 

  • Brunstein CG, Petersdorf EW, DeFor TE, Noreen H, Maurer D, MacMillan ML et al (2016) Impact of allele-level HLA mismatch on outcomes in recipients of double umbilical cord blood transplantation. Biol Blood Marrow Transplant 22(3):487–492

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

Special thanks to Dr. Claudio Brunstein for his critical review of the chapter.

Author information

Authors and Affiliations

  1. Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN, USA

    Erica Warlick MD

Authors
  1. Erica Warlick MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Duke Cancer Center, Duke University, Durham, North Carolina, USA

    Mitchell Horwitz

  2. Duke Cancer Center, Duke University, Durham, North Carolina, USA

    Nelson Chao

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Warlick, E. (2017). Cord Blood Transplants for Myeloid Malignancies in Adults. In: Horwitz, M., Chao, N. (eds) Cord Blood Transplantations. Advances and Controversies in Hematopoietic Transplantation and Cell Therapy. Springer, Cham. https://doi.org/10.1007/978-3-319-53628-6_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-53628-6_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-53627-9

  • Online ISBN: 978-3-319-53628-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation